All Stories

  1. Beyond genotype‐4: Direct‐acting antiviral agents in patients with chronic hepatitis C infection from the Eastern Province of Saudi Arabia
  2. Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia
  3. A global research priority agenda to advance public health responses to fatty liver disease
  4. Emergence of Post COVID-19 Vaccine Autoimmune Diseases: A Single Center Study
  5. Molecular and Genetic Characterization of Hepatitis B Virus (HBV) among Saudi Chronically HBV-Infected Individuals
  6. Genetic Subtypes and Natural Resistance Mutations in HCV Genotype 4 Infected Saudi Arabian Patients
  7. Genetic Subtypes and Natural Resistance Mutations in HCV Genotype 4 Infected Saudi Arabian Patients
  8. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
  9. Concomitant hepatic tuberculosis and hepatocellular carcinoma: a case report and review of the literature
  10. Entecavir versus other oral antiviral drugs for chronic hepatitis B
  11. Analysis of the Impact of Common Polymorphisms of the FTO and MC4R Genes with the Risk of Severe Obesity in Saudi Arabian Population
  12. Entecavir for chronic hepatitis B
  13. SASLT practice guidelines: Management of hepatitis C virus infection
  14. SASLT practice guidelines for the management of hepatitis C virus infection: Summary of recommendations
  15. Frequency of low bone mineral density in Saudi patients with inflammatory bowel disease
  16. Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
  17. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic
  18. Glypican-3-Expressing Hepatocellular Carcinoma in a Non-Cirrhotic Patient with Nonalcoholic Steatohepatitis: Case Report and Literature Review
  19. Rectal prolapse associated with extensive anorectal condyloma acuminata
  20. Reversal of liver fibrosis